THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION…
MaaT PharmaNovember 14, 2025
MaaT Pharma Reports Financial Results for the Third Quarter 2025 and Provides Financing Update The…
MaaT PharmaNovember 4, 2025
MaaT Pharma Publishes its Half Year 2025 Results and Provides a Business Update Positive results…
MaaT PharmaSeptember 17, 2025
MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step…
MaaT PharmaJuly 28, 2025
MaaT Pharma: Half-year Report to the Liquidity Contract With Kepler Cheuvreux Lyon, France, July 24,…
MaaT PharmaJuly 24, 2025
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaJuly 7, 2025
MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting Lyon, France,…
MaaT PharmaJune 24, 2025
June 19, 2025: MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2025
MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2025 Marketing Authorization…
MaaT PharmaJune 19, 2025
MaaT Pharma to Hold Annual General Meeting on June 20, 2025 Lyon, France, May 14,…
MaaT PharmaMay 14, 2025
